OTC Pharmaceuticals - Eastern Africa

  • Eastern Africa
  • Revenue in the OTC Pharmaceuticals market amounts to US$1,504.00m in 2024. The market is expected to grow annually by 8.08% (CAGR 2024-2029).
  • The market's largest segment is the segment Vitamins & Minerals with a market volume of US$452.90m in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$3.28 are generated in 2024.
  • In the OTC Pharmaceuticals market, 2.0% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Eastern Africa is experiencing significant growth and development. Customer preferences in the region are shifting towards self-medication and over-the-counter (OTC) products.

Consumers are becoming more health-conscious and are seeking convenient and affordable healthcare solutions. This trend is driven by factors such as increasing urbanization, rising disposable incomes, and a growing middle class. Additionally, the prevalence of minor ailments and chronic diseases, such as cold and flu, allergies, and digestive disorders, is also contributing to the demand for OTC pharmaceuticals.

Trends in the market indicate a rise in the availability and accessibility of OTC pharmaceutical products. Pharmacies and drugstores are expanding their product offerings to include a wide range of OTC medications, including pain relievers, cough and cold remedies, vitamins and supplements, and gastrointestinal products. This expansion is driven by the growing demand for these products and the increasing number of retail outlets in the region.

Furthermore, the rise of e-commerce platforms and online pharmacies is also contributing to the growth of the OTC pharmaceutical market, providing consumers with convenient access to a variety of products. Local special circumstances in Eastern Africa play a role in the development of the OTC Pharmaceuticals market. The region has a high burden of communicable diseases, such as malaria and HIV/AIDS, which has led to increased government spending on healthcare and pharmaceuticals.

This investment has improved healthcare infrastructure and access to medicines, including OTC pharmaceuticals. Additionally, cultural factors, such as the preference for traditional remedies and herbal medicines, have also influenced the demand for OTC products. Many consumers in the region still rely on traditional healing practices, and this has created a market for herbal and natural OTC remedies.

Underlying macroeconomic factors, such as population growth, urbanization, and economic development, are driving the growth of the OTC Pharmaceuticals market in Eastern Africa. The region has a young and growing population, which is increasing the demand for healthcare services and products. Urbanization is also contributing to the growth of the market, as more people move to cities and have access to a wider range of healthcare options.

Economic development and rising disposable incomes are enabling consumers to afford OTC pharmaceuticals and prioritize their health and well-being. In conclusion, the OTC Pharmaceuticals market in Eastern Africa is experiencing significant growth and development due to changing customer preferences, expanding product availability, local special circumstances, and underlying macroeconomic factors. As the region continues to develop and its healthcare infrastructure improves, the demand for OTC pharmaceuticals is expected to further increase.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)